Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scatena

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Expert Opinion on Investigational Drugs|November 4, 2000
Bivalirudin: a new generation antithrombotic drugR Scatena
Expert Opinion on Investigational Drugs|November 4, 2000
Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseasesR Scatena
Idrugs : the Investigational Drugs Journal|September 15, 2005
Bucindolol (Bristol-Myers Squibb Co)R Scatena
Pediatria De Las Americas|October 29, 2010
Fever and dentition in the infantA R SCATENA
Expert Opinion on Biological Therapy|December 1, 2001
O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrierR Scatena, B Giardina
La Clinica Terapeutica|December 31, 1986
[Heparin: uses and possibility. Current status]G Conte, R Scatena, B Santinelli
Critical Reviews in Biochemistry and Molecular Biology|January 1, 1995
The multiple functions of hemoglobinB Giardina, I Messana, R Scatena, et al.
Journal of Bioluminescence and Chemiluminescence|July 1, 1996
Monocyte oxygenation activities are significantly influenced by non-enzymatic glycosylation of collagenR Scatena, G Nocca, P De Sole, et al.
Journal of Bioluminescence and Chemiluminescence|December 5, 1998
Impaired reactive oxygen metabolism of phagocytic leukocytes in NIDDM patients. A role for non-enzymatic glycosylation of collagenR Scatena, G Nocca, P De Sole, et al.
American Journal of Physical Anthropology|June 23, 1999
Brief communication: Resistance to Falciparum malaria in alpha-thalassemia, oxidative stress, and hemoglobin oxidationG Destro-Bisol, E D'Aloja, G Spedini, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|November 4, 2000
Bivalirudin: a new generation antithrombotic drugR Scatena
Expert Opinion on Investigational Drugs|November 4, 2000
Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseasesR Scatena
Idrugs : the Investigational Drugs Journal|September 15, 2005
Bucindolol (Bristol-Myers Squibb Co)R Scatena
Pediatria De Las Americas|October 29, 2010
Fever and dentition in the infantA R SCATENA
Expert Opinion on Biological Therapy|December 1, 2001
O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrierR Scatena, B Giardina
La Clinica Terapeutica|December 31, 1986
[Heparin: uses and possibility. Current status]G Conte, R Scatena, B Santinelli
Critical Reviews in Biochemistry and Molecular Biology|January 1, 1995
The multiple functions of hemoglobinB Giardina, I Messana, R Scatena, et al.
Journal of Bioluminescence and Chemiluminescence|July 1, 1996
Monocyte oxygenation activities are significantly influenced by non-enzymatic glycosylation of collagenR Scatena, G Nocca, P De Sole, et al.
Journal of Bioluminescence and Chemiluminescence|December 5, 1998
Impaired reactive oxygen metabolism of phagocytic leukocytes in NIDDM patients. A role for non-enzymatic glycosylation of collagenR Scatena, G Nocca, P De Sole, et al.
American Journal of Physical Anthropology|June 23, 1999
Brief communication: Resistance to Falciparum malaria in alpha-thalassemia, oxidative stress, and hemoglobin oxidationG Destro-Bisol, E D'Aloja, G Spedini, et al.
Pageof 4